Kineret (anakinra) — Point32Health

Initial criteria

• Documented diagnosis of rheumatoid arthritis
• Patient age ≥ 18 years
• Prescribed by or in consultation with a rheumatologist
• Trial and failure of at least two of the listed medications from each of the following therapeutic categories (only one medication is required if only one is available for a listed therapeutic category): Interleukin Antagonists: Actemra; Janus Kinase Inhibitors: Olumiant, Rinvoq, Xeljanz; Selective T Cell Stimulators: Orencia; Tumor Necrosis Factors: Cimzia, Enbrel, Humira, Simponi OR Contraindication to all of the following medications: Actemra, Olumiant, Rinvoq, Xeljanz, Orencia, Cimzia, Enbrel, Humira, Simponi